Physician profile
David R Wright
NPI 1689917007
$1,885.09
in general payments reported to CMS, 2019-2025
10 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2022: $16.03 · 2023: $228 · 2024: $499 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $786.50 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $261.94 | 2019-2023 | |
| Keswick Pharmaceuticals LLC | $246.36 | 2019 | |
| Convatec INC. | $167.25 | 2023-2025 | |
| Genentech USA, INC. | $120.72 | 2019 | |
| Lilly USA, LLC | $99.73 | 2019 | |
| Galderma Laboratories, L.P. | $80.52 | 2019-2022 | |
| Progenacare Global, LLC | $50.80 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $43.68 | 2019-2023 | Libtayo |
| Organogenesis INC. | $27.59 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.